Insiders · Profile

ZDRAVESKI ZORAN

See Remarks at TScan Therapeutics · See Remarks at Dianthus Therapeutics, Inc. /DE/. Filing since 23 Dec 2019. CIK 0001741285

Company

Date

Role

Action

Amount

Of holding

23 Aug 2024

See Remarks

Sold at will

164,686

$952.12K

97.2%

23 Sep 2021

Chief Legal Officer

Bought

4,716

$35.26K

opened

24 Dec 2019

See Remarks

Sold, plan not stated

7,902

$126.43K

5.8%

23 Dec 2019

See Remarks

Sold, plan not stated

4,181

$67.02K

3.0%

4 decisions on file.